prednisolone has been researched along with Keratoacanthoma in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Keratoacanthoma: A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, the risk of acquiring skin cancer increases with the length of immunosuppressive therapy." | 2.67 | No difference in skin cancer incidence with or without cyclosporine--a 5-year perspective. ( Blohmé, I; Larkö, O, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dessoukey, MW | 1 |
| Omar, MF | 1 |
| Abdel-Dayem, H | 1 |
| Blohmé, I | 1 |
| Larkö, O | 1 |
| Cabotin, PP | 1 |
| Vignon-Pennamen, MD | 1 |
| Miclea, JM | 1 |
| D'Agay, MF | 1 |
| Wallach, D | 1 |
1 trial available for prednisolone and Keratoacanthoma
| Article | Year |
|---|---|
No difference in skin cancer incidence with or without cyclosporine--a 5-year perspective.
Topics: Azathioprine; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Foll | 1992 |
2 other studies available for prednisolone and Keratoacanthoma
| Article | Year |
|---|---|
Eruptive keratoacanthomas associated with immunosuppressive therapy in a patient with systemic lupus erythematosus.
Topics: Adult; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Keratoacanthoma; Lupus E | 1997 |
[Multiple eruptive keratoacanthoma disclosing lymphoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1989 |